NCH Continues its Expansion of Cancer Program with New Specialists and Services
NCH Continues its Expansion of Cancer Program with New Specialists and Services South Florida Hospital News
🎗️
Онкология
🎗️Лента новостей
Онкология
U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer
U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer BioSpace
Онкология
Oncolytics Biotech Announces Progress in REO 033 Trial, Site Activations and FDA-Aligned Pathway for Pelareorep in Metastatic Colorectal Cancer
Oncolytics Biotech Announces Progress in REO 033 Trial, Site Activations and FDA-Aligned Pathway for Pelareorep in Metastatic Colorectal Cancer Quiver Quantitative
🎗️
Онкология
Bundled Payments in Community Oncology: Making It Work
Bundled Payments in Community Oncology: Making It Work Oncology News Central
Онкология
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer Investing News Network
Онкология
After prostate surgery, shortened radiation schedule provides similar cancer control to standard radiation
Men with high-risk prostate cancer have a higher likelihood of residual disease after prostatectomy and may require radiation therapy after surgery, particularly when PSA levels begin to rise. Conventional postprostatectomy radiotherapy (COPORT) is typically delivered over 37 fractions, while hypofractionated…
🎗️
Онкология
Alisertib Phase 2 Combo Trial Launches in Small Cell Lung Cancer
Alisertib Phase 2 Combo Trial Launches in Small Cell Lung Cancer Targeted Oncology
Онкология
Siemens Healthineers Launches Accela Radiotherapy System With 60-Second SBRT Capability
Siemens Healthineers Launches Accela Radiotherapy System With 60-Second SBRT Capability Pulse 2.0
Онкология
New CRISPR activation platform uncovers genetic drivers of cancer resistance
New CRISPR activation platform uncovers genetic drivers of cancer resistance Drug Discovery News
Онкология
Старая хирургическая практика удивила врачей: что изменило шансы столкнуться с опухолью в два раза
Старая хирургическая практика удивила врачей: что изменило шансы столкнуться с опухолью в два раза Правда.Ру
Онкология
How missing pieces of the Y chromosome drive cancer in men
A new study found that cancer cells selectively chip away gene-rich sections of the Y chromosome, triggering changes that regulate tumor growth. Co-led by University of Arizona Cancer Center physician-scientist Dr. Dan Theodorescu, the paper, "Recurrent deletions and regulatory disruption of the Y chromosome in…
Онкология
Genetic profiling could help tailor hormone therapy for prostate cancer after surgery
A recent analysis of the NRG-RTOG 0534 "SPPORT" clinical trial evaluated the Luminal B (LumB) molecular subtype using the PAM50 genomic classifier to determine whether tumor biology could help identify patients most likely to benefit from hormone therapy.
Онкология
Chemotherapy hair loss distress higher in young, Black women
Black women with breast cancer were more likely to experience distress from chemotherapy-induced hair loss at younger ages compared with older women, according to a pilot study published in the Journal of the American Academy of Dermatology. “Chemotherapy-induced alopecia affects the majority of patients receiving…
Онкология
Merck, Daiichi end plans to seek speedy approval of lung cancer ADC
Merck, Daiichi end plans to seek speedy approval of lung cancer ADC BioPharma Dive